Market Closed -
Japan Exchange
02:00:00 2024-07-10 am EDT
5-day change
1st Jan Change
1,849
JPY
0.00%
+0.16%
-16.45%
Nakano Shoten Co., Ltd agreed to acquire 9.7% stake in WDB Holdings Co., Ltd. from Toshimitsu Nakano.
Nakano Shoten Co., Ltd agreed to acquire 9.7% stake in WDB Holdings Co., Ltd. (TSE:2475) from Toshimitsu Nakano on February 8, 2019. Nakano Shoten will acquire 1.9 million shares of WDB Holdings. The transaction is expected to complete on February 12, 2019.
WDB Holdings Co., Ltd. Announces the Resignation of Shuji Kondo as Managing Director, Effective from March 31, 2024
Mar. 15
CI
TerrAscend Announced $37 Million Paydown of Senior Secured Term Loan in Pennsylvania
23-06-30
MT
WDB Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023
23-05-12
CI
TerrAscend Cuts Outstanding Debt
22-11-30
MT
Tranche Update on WDB Holdings Co., Ltd.'s Equity Buyback Plan announced on November 11, 2022.
22-11-13
CI
WDB Holdings Co., Ltd.'s Equity Buyback announced on November 11, 2022, has closed with 100,000 shares, representing 0.51% for ¥258.3 million.
22-11-13
CI
WDB Holdings Co., Ltd. announces an Equity Buyback for 100,000 shares, representing 0.51% for ¥300 million.
22-11-11
CI
WDB Holdings Co., Ltd. authorizes a Buyback Plan.
22-11-10
CI
An unknown buyer completed the acquisition of Kaken Geneqs Inc. from WDB Holdings Co., Ltd..
22-02-24
CI
An unknown buyer agreed to acquire Kaken Geneqs Inc. from WDB Holdings Co., Ltd. for approximately ¥200 million.
22-01-19
CI
Tranche Update on WDB Holdings Co., Ltd.'s Equity Buyback Plan announced on February 5, 2021.
21-02-07
CI
WDB Holdings Co., Ltd.'s Equity Buyback announced on February 5, 2021, has closed with 100,000 shares, representing 0.5% for ¥274.8 million.
21-02-07
CI
WDB Holdings Co., Ltd. announces an Equity Buyback for 100,000 shares, representing 0.5% for ¥300 million.
21-02-05
CI
WDB Holdings Co., Ltd. authorizes a Buyback Plan.
21-02-04
CI
Nakano Shoten Co., Ltd cancelled the acquisition of 9.7% stake in WDB Holdings Co., Ltd. from Toshimitsu Nakano.
20-02-07
CI
Wdb Holdings Co., Ltd. Reports Consolidated Earnings Results for the Third Quarter of 2019; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2020
20-02-06
CI
WDB coco Co., Ltd. has completed an IPO in the amount of ¥875.16 million.
19-12-24
CI
WDB coco Co., Ltd. has filed an IPO.
19-11-20
CI
WDB Holdings Co., Ltd. Reports Consolidated Earnings Results for the Second Quarter Ended September 30, 2019; Provides Earnings Guidance for the Year Ending March 31, 2020
19-11-07
CI
WDB Holdings Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2019; Provides Consolidated Earnings Guidance for the Second Quarter and Fiscal Year 2020
19-08-08
CI
Nakano Shoten Co., Ltd agreed to acquire 9.7% stake in WDB Holdings Co., Ltd. from Toshimitsu Nakano.
19-02-07
CI
An unknown buyer completed the acquisition of WDB Environmental & Biological Research Institute Co., Ltd. from WDB Holdings Co., Ltd..
18-12-30
CI
An unknown buyer signed a contract to acquire WDB Environmental & Biological Research Institute co., Ltd. from WDB Holdings Co., Ltd..
18-12-06
CI
WDB Holdings Co., Ltd. Reports Consolidated Earnings Results for the Fiscal Year Ended March 31, 2018; Provides Consolidated Earnings Guidance for the Second Quarter and Fiscal Year Ending March 31, 2019
18-05-10
CI
Tranche Update on WDB Holdings Co., Ltd.'s Equity Buyback Plan announced on February 9, 2018.
18-02-13
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
WDB HOLDINGS CO., LTD. is a company mainly engaged in the manpower dispatching business. The Company operates in two business segments. The Human Resource Service segment is engaged in the work of client customers mainly through temporary staffing and contracting contracts. The CRO (Contract Research Organization) business segment acts on and supports experimental work in basic research of pharmaceuticals, quasi-drugs, cosmetics and development work after clinical trial. The other business is engaged in the contracted manufacture of organic chemicals, as well as the product development and sale, and the research of the aquaculture and breeding of clams, fishes and algae, among others.
More about the company
Last Close Price
1,849
JPY
Average target price
2,800
JPY
Spread / Average Target
+51.43%
Consensus
1st Jan change
Capi.
-16.45% 225M -24.10% 8.08B -30.54% 6.28B -28.23% 5.39B +4.21% 3.5B +5.96% 1.45B -12.38% 1.28B -18.12% 1.21B -12.17% 1.11B -3.98% 844M
Other Employment Services
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1